-
Barr I G, Hurt A C, Deed N. The emergence of adamantane resistance in influenza A (H1) viruses in Australia and regionally in 2006[J]. Antiviral Res, 2007a, 75(): 173-176. doi: 10.1016/j.antiviral.2007.01.006
-
Barr I G, Hurt A C, Iannello P. Increased adamantane resistance in influenza A (H3) viruses in Australia and neighbouring countries in 2005[J]. Antiviral Res, 2007b, 73(): 112-117. doi: 10.1016/j.antiviral.2006.08.002
-
Bright R A, Medina M J, Xu X. Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern[J]. Lancet, 2005, 366(): 1175-1181. doi: 10.1016/S0140-6736(05)67338-2
-
Bright R A, Shay D K, Shu B. Adamantane resistance among influenzaAviruses isolated early during the 2005-2006 influenza season in the United States[J]. JAMA, 2006, 295(): 891-894. doi: 10.1001/jama.295.8.joc60020
-
Cheung C L, Rayner J M, Smith G J. Distribution of amantadine-resistant H5N1 avian influenza variants in Asia[J]. J Infect Dis, 2006, 193(): 1626-1629. doi: 10.1086/jid.2006.193.issue-12
-
Deyde V M, Okomo-Adhiambo M, Sheu T G. Pyrosequencing as a tool to detect molecular markers of resistance to neuraminidase inhibitors in seasonal influenza A viruses[J]. Antivir Res, 2009, 81(): 16-24. doi: 10.1016/j.antiviral.2008.08.008
-
Garman E, Laver G. Controlling influenza by inhibiting the virus’s neu-raminidase[J]. Curr Drug Targets, 2004, 5(): 119-136. doi: 10.2174/1389450043490604
-
Hayden F G, Hay A J. Emergence and transmission of influenza A viruses resistant to amantadine and rimantadine[J]. Curr Top Microbiol Immunol, 1992, 176(): 119-130.
-
Hayden F, Klimov A, Tashiro M. Neuraminidase inhibitor susceptibility network position statement: antiviral resistance in influenza A/H5N1 viruses[J]. Antiviral Ther, 2005, 10(): 873-877.
-
Ilyushina N A, Govorkova E A, Webster R G. Detection of amantadine-resistant variants among avian influenza viruses isolated in North America and Asia[J]. Virology, 2005, 341(): 102-106. doi: 10.1016/j.virol.2005.07.003
-
Puthavathana P, Auewarakul P, Charoenying P C. Molecular characterization of the complete genome of human influenza H5N1virus isolates from Thailand[J]. J Gen Virol, 2005, 86(): 423-433. doi: 10.1099/vir.0.80368-0
-
Palese P. Influenza: old and new threats[J]. Nat Med, 2004, 10(): S82-S87. doi: 10.1038/nm1141
-
Saito R, Li D, Suzuki Y. High prevalence of amantadine-resistance influenza A (H3N2) in six prefectures, Japan, in the 2005-2006 season[J]. J Med Virol, 2007, 79(): 1569-1576. doi: 10.1002/(ISSN)1096-9071
-
Sheu T G, Deyde V M, Okomo-Adhiambo M. Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004-2008[J]. Antimicrob Agents Chemother, 2008, 52(): 3284-3292. doi: 10.1128/AAC.00555-08
-
Shiraishi K, Mitamura K, Sakai-Tagawa Y. High frequency of resistant viruses harboring different muta-tions in amantadine-treated children with influenza[J]. J Infect Dis, 2003, 188(): 57-61. doi: 10.1086/jid.2003.188.issue-1
-
Wutzler P, Kossow K D, Lode H. Antiviral treatment and prophylaxis of influenza in primary care: German recommenda-tions[J]. J Clin Virol, 2004, 31(): 84-91. doi: 10.1016/j.jcv.2004.05.009